FDA Approves Trabectedin for Certain Types of Advanced Soft Tissue Sarcoma

Yes

Approval concerns treatment of patients with unresectable and advanced liposarcoma and leiomyosarcoma

No relation
No
27/10/2015 3:28 pm
There are no related objects.